vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $140.7M, roughly 1.4× Purple Innovation, Inc.). Purple Innovation, Inc. runs the higher net margin — -2.3% vs -14.6%, a 12.3% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 9.1%). Purple Innovation, Inc. produced more free cash flow last quarter ($-7.8M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 8.3%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
AXSM vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $140.7M |
| Net Profit | $-28.6M | $-3.2M |
| Gross Margin | — | 41.9% |
| Operating Margin | -13.8% | -1.6% |
| Net Margin | -14.6% | -2.3% |
| Revenue YoY | 65.0% | 9.1% |
| Net Profit YoY | 61.9% | 62.1% |
| EPS (diluted) | $-0.55 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $140.7M | ||
| Q3 25 | $171.0M | $118.8M | ||
| Q2 25 | $150.0M | $105.1M | ||
| Q1 25 | $121.5M | $104.2M | ||
| Q4 24 | $118.8M | $129.0M | ||
| Q3 24 | $104.8M | $118.6M | ||
| Q2 24 | $87.2M | $120.3M | ||
| Q1 24 | $75.0M | $120.0M |
| Q4 25 | $-28.6M | $-3.2M | ||
| Q3 25 | $-47.2M | $-11.7M | ||
| Q2 25 | $-48.0M | $-17.3M | ||
| Q1 25 | $-59.4M | $-19.1M | ||
| Q4 24 | $-74.9M | $-8.5M | ||
| Q3 24 | $-64.6M | $-39.2M | ||
| Q2 24 | $-79.3M | $27.0K | ||
| Q1 24 | $-68.4M | $-50.2M |
| Q4 25 | — | 41.9% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | — | 35.9% | ||
| Q1 25 | — | 39.4% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | — | 29.7% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 34.8% |
| Q4 25 | -13.8% | -1.6% | ||
| Q3 25 | -27.0% | -10.2% | ||
| Q2 25 | -24.5% | -13.5% | ||
| Q1 25 | -46.9% | -13.9% | ||
| Q4 24 | -61.1% | -6.0% | ||
| Q3 24 | -59.8% | -39.5% | ||
| Q2 24 | -89.5% | -12.1% | ||
| Q1 24 | -89.7% | -19.3% |
| Q4 25 | -14.6% | -2.3% | ||
| Q3 25 | -27.6% | -9.9% | ||
| Q2 25 | -32.0% | -16.5% | ||
| Q1 25 | -48.9% | -18.4% | ||
| Q4 24 | -63.1% | -6.6% | ||
| Q3 24 | -61.7% | -33.1% | ||
| Q2 24 | -91.0% | 0.0% | ||
| Q1 24 | -91.1% | -41.8% |
| Q4 25 | $-0.55 | $0.03 | ||
| Q3 25 | $-0.94 | $0.11 | ||
| Q2 25 | $-0.97 | $0.16 | ||
| Q1 25 | $-1.22 | $0.18 | ||
| Q4 24 | $-1.54 | $0.08 | ||
| Q3 24 | $-1.34 | $0.36 | ||
| Q2 24 | $-1.67 | $0.00 | ||
| Q1 24 | $-1.44 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $88.3M | $-29.7M |
| Total Assets | $689.8M | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $24.3M | ||
| Q3 25 | $325.3M | $32.4M | ||
| Q2 25 | $303.0M | $34.2M | ||
| Q1 25 | $300.9M | $21.6M | ||
| Q4 24 | $315.4M | $29.0M | ||
| Q3 24 | $327.3M | $23.4M | ||
| Q2 24 | $315.7M | $23.4M | ||
| Q1 24 | $331.4M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $88.3M | $-29.7M | ||
| Q3 25 | $73.7M | $-26.9M | ||
| Q2 25 | $73.1M | $-15.6M | ||
| Q1 25 | $53.2M | $1.3M | ||
| Q4 24 | $57.0M | $20.2M | ||
| Q3 24 | $92.9M | $28.0M | ||
| Q2 24 | $102.9M | $66.4M | ||
| Q1 24 | $144.0M | $65.5M |
| Q4 25 | $689.8M | $296.3M | ||
| Q3 25 | $669.3M | $302.1M | ||
| Q2 25 | $639.8M | $303.8M | ||
| Q1 25 | $596.7M | $293.8M | ||
| Q4 24 | $568.5M | $307.8M | ||
| Q3 24 | $561.5M | $309.3M | ||
| Q2 24 | $548.2M | $362.1M | ||
| Q1 24 | $545.7M | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $-5.8M |
| Free Cash FlowOCF − Capex | $-18.7M | $-7.8M |
| FCF MarginFCF / Revenue | -9.6% | -5.5% |
| Capex IntensityCapex / Revenue | 0.0% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $-5.8M | ||
| Q3 25 | $1.0M | $-968.0K | ||
| Q2 25 | $-32.4M | $-4.0M | ||
| Q1 25 | $-43.4M | $-23.1M | ||
| Q4 24 | $-26.2M | $6.8M | ||
| Q3 24 | $-18.6M | $1.1M | ||
| Q2 24 | $-30.1M | $-8.9M | ||
| Q1 24 | $-53.5M | $-16.8M |
| Q4 25 | $-18.7M | $-7.8M | ||
| Q3 25 | $988.0K | $-1.8M | ||
| Q2 25 | $-32.4M | $-7.0M | ||
| Q1 25 | $-43.7M | $-25.3M | ||
| Q4 24 | $-26.2M | $5.7M | ||
| Q3 24 | $-18.7M | $101.0K | ||
| Q2 24 | $-30.2M | $-11.0M | ||
| Q1 24 | $-53.6M | $-19.9M |
| Q4 25 | -9.6% | -5.5% | ||
| Q3 25 | 0.6% | -1.5% | ||
| Q2 25 | -21.6% | -6.6% | ||
| Q1 25 | -36.0% | -24.3% | ||
| Q4 24 | -22.1% | 4.4% | ||
| Q3 24 | -17.9% | 0.1% | ||
| Q2 24 | -34.6% | -9.2% | ||
| Q1 24 | -71.4% | -16.5% |
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.3% | 2.2% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.1% | 0.9% | ||
| Q2 24 | 0.1% | 1.7% | ||
| Q1 24 | 0.1% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
